The impact of copeptin levels on coronary atherosclerotic lesions in postmenopausal women with impaired glucose tolerance

Kai ZHANG,Wen-xing HU,Hui-ming YIN,Xiao-li YUAN,Xin-zheng LU,Xian-xian ZHAO

DOI: https://doi.org/10.3969/j.issn.1672-271X.2017.01.007

2017-01-01

Abstract:Objective To observe the impact of copeptin levels on coronary atherosclerotic lesions in postmenopausal women with impaired glucose tolerance ( IGT ) . Methods 80 postmenopausal women ( aged 56-59 years ) with the onset of IGT ( fasting blood glucose, i. e. FBG ≤ 6. 2 mmol/L, 7. 8 mmol/L≤2-hour postprandial blood glucose,i. e. 2hPBG≤9. 4 mmol/L ) were divided into control group ( copeptin <5 pmol/L) and high-copeptin group ( copeptin > 20 pmol/L) , according to serum copeptin levels at baseline, 40 cases in each group. The discrepancy of coronary CTA stenosis scores were analyzed between the two groups at baseline and after 3-months follow-up. Results ①At baseline, the difference was statisti-cally significant in copeptin levels ( P<0. 05 ) , but not in weight, FBG, 2hPBG, fasting serum triglyceride (TG), total serum cholesterol ( TC ) , serum low-density lipoprotein cholesterol(LDL-C), mean arterial pressure, serum creatinine and age between the two groups ( P>0. 05) . ②After 3-months thera eutic lifestyle adjustment as well as oral administration of aspirin (100 mg qd) and rosuvastain (10 mg qd), copeptin level, coronary CTA stenosis scores, and 2hPBG of high-copeptin group were sta-tistically significantly higher compared with control group respectively(P<0. 05). Furthermore, some cases developed coronary heart disease ( CHD) in high-copeptin group, while not in control group. Conclusion On the basis of the influence of the atherosclerotic risk factors of IGT and postmenopausal female, high plasma copeptin level will further promote the occurrence and deterioration of coro-nary atherosclerotic lesions.